Bar-Ilan University has become a partner in an €8 million European project to make advanced cancer treatment faster, safer, and more widely available.

The five-year program, funded through the European Union’s Innovative Health Initiative, aims to automate the production of CAR-T cell therapy so hospitals can provide it directly to patients within 24 hours.

CAR-T therapy uses a patient’s own immune cells, genetically modified to fight cancer.